Understand how our ASV algorithm PaceWave™ works
Click to discover how the algorithm reacts when an event occurs
PaceWave algorithm offers
When can you prescribe ASV therapy?
The ERS statement about the treatment of central breathing disturbances during sleep
Adapted from the ERS statement about CSA7
Register to ResMed clinical newsletter
Stay aware of the latest clinical updates on CSA, OSA and ResMed latest innovations.
* ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central sleep apnoea.
- Pépin JL et al. Adherence to positive airway therapy after switching from CPAP to ASV: a big data analysis. J Clin Sleep Med. 2018;14(1):57–63.
- Cistulli PA, Armitstead J, Pepin JL, Woehrle H, Nunez CM, Benjafield A, Malhotra A. Short-term CPAP adherence in obstructive sleep apnoea: a big data analysis using real world data. Sleep Med. 2019 Jan 11. Pi:S1389-9457(18)30797-4.
- Carnevale et al. Effectiveness of Adaptive Servo-Ventilation in the treatment of hypocapnic central sleep apnoea of various etiologies Sleep Medicine 2011 Dec;12(10):952-8
- Allan et al. Efficacy of adaptive servo ventilation in treatment of complex and central sleep apnoea syndromes Chest 2007;132:1839-46
- Morgenthaler et al. Adaptive servoventilation versus noninvasive postive pressure ventilation for central, mixed and complex sleep apnoea sydromes. Sleep 2007 ; 30(4) :468-75
- Brown et al. A retrospective case series of adaptive servoventilation for complex sleep apnoea. J Clin Sleep Med 2011 ;7(2):187-95
- Randerath W et al. Defintion, discrimination, diagnosis and treatment of central breathing disturbances during sleep ERJ Express. Published on December 5, 2016 as doi: 10.1183/13993003.00959-2016